The full record
More than a decade building and governing AI and biotech from inside the institutions that decide what happens to them. Most recent first.
Vigilance Division, Alloy Therapeutics
Chief Executive Officer
Building the division that turns Alloy’s platform into biosecurity countermeasures the country can actually deploy.
National Security Commission on Emerging Biotechnology
Commissioner, appointed by Congress
Charting the Future of Biotechnology, the national action plan for keeping the country ahead in biotech, delivered to Congress.
National Academies of Sciences, Engineering, and Medicine
Consensus study committee
The Age of AI in the Life Sciences: Benefits and Biosecurity Considerations.
Avidity Biosciences
Vice President, AI & Machine Learning
Built the company’s first enterprise AI organization and put it to work across drug discovery and the business.
U.S. Senate AI Insight Forum
Invited expert testimony
Testimony on measuring the risk of AI in biology instead of guessing.
Colossal Biosciences
Entrepreneur-in-Residence and VP, Strategy & Computational Sciences
Turns out you can change a tiger’s stripes these days.
Google Public Sector
Head of Healthcare & Life Sciences Strategy
Scaled the Intelligent Vaccine Impact solution to more than thirty state and national governments during the COVID-19 response.
U.S. Department of Defense
Inaugural head of biotechnology strategy
Built the Pentagon’s first enterprise biotechnology strategy, the groundwork that launched BioMADE.
Amazon
Research Fellow, Alexa AI
A research fellowship in applied machine learning, understanding the nuance of machine language before Large Language Models (LLMs).